Interacting signaling pathways in the pathogenesis of squamous cell carcinoma.
Yuspa
S H
SH
Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, National Institutes of Health and Laboratory of Immunobiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA.
Hansen
L
L
Li
L
L
Joseloff
E
E
Weinberg
W
W
Fernandez-Salas
E
E
D000818:Animals; D017209:Apoptosis / Q000502:physiology; D002294:Carcinoma, Squamous Cell / Q000209:etiology* / Q000235:genetics; D016923:Cell Death / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D066246:ErbB Receptors / Q000502:physiology*; D006197:Hair / Q000254:growth & development; D006801:Humans; D015603:Keratinocytes / Q000502:physiology; D051379:Mice; D009154:Mutation; D011230:Precancerous Conditions / Q000209:etiology / Q000235:genetics; D011493:Protein Kinase C / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology*; D012878:Skin Neoplasms / Q000209:etiology* / Q000235:genetics
D066246:ErbB Receptors; D011493:Protein Kinase C